Overview Request Sample Pages Request Customization Download PDF
You are viewing: North America Gastrointestinal Stent Market analysis
Part of: Gastrointestinal Stent Market (Global)

The North America Gastrointestinal Stent Market was valued at $243.8 Million in 2026 and projected to reach to $318.6 Million by 2031, representing a compound annual growth rate of 5.5%. North America's gastrointestinal stent market is poised for sustained growth through 2031, driven by an aging demographic, increasing prevalence of esophageal and biliary disorders, and strong healthcare spending.

North America Gastrointestinal Stent Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America Gastrointestinal Stent Market Trends and Insights

  • North America maintains a significant share of the global gastrointestinal stent market, driven by advanced healthcare infrastructure, high procedural volumes, and strong adoption of minimally invasive technologies.
  • The region benefits from established reimbursement frameworks and a robust patient population requiring endoscopic interventions for biliary, esophageal, and colorectal conditions. Growth in North America is supported by increasing prevalence of gastrointestinal disorders, aging demographics, and continuous innovation in stent design and delivery systems.
  • North America's healthcare providers are increasingly adopting self-expanding metal stents (SEMS) and fully covered stents to improve clinical outcomes and reduce complications.
  • The competitive landscape in North America remains dynamic, with both established medical device manufacturers and emerging players investing in product development and market expansion strategies..

Key Market Statistics

  • CAGR (2026-2031) 5.5% CAGR
  • Market Size, 2026 ~USD 243.8 Million
  • Forecast, 2031 ~USD 318.6 Million
  • Geography North America

North America Gastrointestinal Stent Market Overview

Market Valuation & Growth :

North America's gastrointestinal stent market is valued at $243.8 million in 2026 and is projected to reach $318.6 million by 2031, representing a steady 5.5% CAGR over the forecast period.

Advanced Healthcare Infrastructure :

North America benefits from world-class healthcare systems, state-of-the-art medical facilities, and high adoption rates of cutting-edge minimally invasive technologies that drive gastrointestinal stent utilization.

High Procedural Volumes :

The region experiences significant procedural volumes for gastrointestinal interventions, supported by aging populations, prevalence of GI disorders, and strong reimbursement frameworks that facilitate market expansion.

Minimally Invasive Technology Leadership :

North America leads in the adoption and innovation of minimally invasive endoscopic procedures, positioning the region as a key driver for gastrointestinal stent market growth and technological advancement.

North America Gastrointestinal Stent Market Dynamics

  • The region's advanced medical infrastructure and high procedural adoption rates create a favorable environment for market expansion.
  • Technological innovations in stent design and materials, coupled with improved clinical outcomes, are expected to drive demand across hospitals and ambulatory surgical centers. Reimbursement policies and insurance coverage in the US and Canada remain robust, supporting market penetration.
  • Key growth opportunities lie in expanding applications beyond traditional indications and increasing adoption in smaller healthcare facilities.
  • Competition among major device manufacturers will likely drive innovation and pricing optimization, benefiting healthcare providers and patients while maintaining steady market growth at 5.5% CAGR through 2031..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • North America's gastrointestinal stent market will grow from $243.8M (2026) to $318.6M (2031) at a 5.5% CAGR.
    • North America's advanced healthcare infrastructure and high procedural adoption rates drive market expansion.
    • North America is experiencing increased demand for fully covered and self-expanding metal stents.
    • North America's aging population and rising gastrointestinal disorder prevalence support sustained market growth through 2031.

    Gastrointestinal Stent Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment BIODEGRADABLE STENTS (Type)
    Forecast Period 2026–2031
    Growth Rate CAGR of 5.7% from 2026 to 2031
    Largest Segment HOSPITALS & CLINICS (End User)
    Market Size Base Year (Billions) ~USD 0.62 (2026)
    Revenue Forecast (Billions) ~USD 0.82 (2031)
    Segments Covered Product, Type, Mechanism, Coverage, Application, End User

    North America Gastrointestinal Stent Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Biliary Stents
    • Biodegradable Stents
    • Colonic Stents
    • Duodenal Stents
    • Esophageal Stents
    • Metal Stents
    • Pancreatic Stents
    • Plastic Stents

    By Type

    • Biliary Stents
    • Biodegradable Stents
    • Colonic Stents
    • Colorectal Cancer
    • Duodenal Stents
    • Esophageal Cancer
    • Esophageal Stents
    • Magnesium-Based Stents
    • Metal Stents
    • Nitinol Stents
    • Other Biodegradable Stents
    • Other Metal Stents
    • Pancreatic Cancer
    • Pancreatic Stents
    • Plastic Stents
    • Polymer-Based Stents
    • Stainless Steel Stents
    • Stomach Cancer

    By Mechanism

    • Balloon-Expandable Metal Stents (Bems)
    • Self-Expanding Metal Stents (Sems)

    By Coverage

    • Fully Covered Stents
    • Partially Covered Stents
    • Uncovered Stents

    By Application

    • Benign Strictures & Leaks
    • Biliary Disease
    • Biliary Diseases
    • Gastrointestinal Cancer
    • Other Applications

    By End User

    • Ambulatory Surgical Centers
    • Hospitals & Clinics
    • Specialty Endoscopy Centers/Gi Clinics

    Target Audience

    • Medical Device Manufacturers : Device companies need North America market data to assess market size, growth potential, and competitive positioning in the region's high-value gastrointestinal stent segment.
    • Healthcare Providers & Hospitals : Hospital administrators and procurement teams require market insights to understand procedural trends, technology adoption rates, and vendor landscape to optimize purchasing decisions and clinical outcomes.
    • Investment & Private Equity Firms : Investors evaluating healthcare companies need detailed North America market forecasts and growth drivers to assess investment opportunities and valuation multiples in the gastrointestinal device sector.
    • Market Research & Consulting Firms : Research organizations require granular North America data to support client advisory services, competitive analysis, and strategic recommendations in the medical device and healthcare sectors.
    • Regulatory & Government Bodies : Healthcare policy makers and regulatory agencies benefit from market data to understand technology adoption, healthcare spending trends, and procedural volumes for informed policy development.

    Key Companies in the North America Gastrointestinal Stent Market

    CompanyHQOwnershipStrongest segments
    ATS AUTOMATION TOOLING SYSTEMS INCCanadaPublic CompanyCustom automated manufacturing and assembly systems,Pre- and post-automation services and lifecycle support,Contract manufacturing and integration services,
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (coronary, structural heart, CRM, peripheral),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention),MedSurg – Urology and Pelvic Health,
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions (endoscopes, devices, services),Surgical Endoscopes & Integrated OR Solutions,Advanced Energy Devices,
    M.I. TECHMalaysiaPublic CompanyDie sorting and smart binning equipment,Test handling and vision inspection equipment,Laser bonding and precision bonding equipment,
    MICRO-TECH (NANJING) CO., LTD.ChinaPublic CompanyDigestive endoscopy – ESD and ERCP (therapeutic devices and accessories),Stents and dilation/biopsy systems (biliary, intestinal, esophageal),Hemostasis, EUS, and diagnostic accessories,
    MERIT MEDICAL SYSTEMSUnited StatesPublic CompanyCardiovascular access and intervention (micropuncture, sheaths, guidewires, angiography, hemostasis),Peripheral intervention and embolotherapy (angiography, drainage, delivery, embolic solutions),Oncology and spine (soft tissue biopsy, vertebral augmentation, RF ablation, bone biopsy),
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio,
    STERISIrelandPublic CompanyHealthcare sterilization, decontamination, and OR infrastructure,Applied Sterilization Technologies (outsourced sterilization services),Life sciences contamination control and processing,
    BDUnited StatesPublic CompanyMedical Essentials (IV access, syringes, needles, sharps, vascular care),Connected Care (infusion systems, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems),
    Q3 MEDICAL GROUPIrelandPrivate CompanySpecialty procedures and interventions,Outpatient and ambulatory services,Diagnostics and imaging,
    BVMTunisiaPublic CompanyFire, miscellaneous accidents, and engineering,Marine, energy, and aviation (including pools),Agricultural and emerging risks,

    ATS AUTOMATION TOOLING SYSTEMS INC

    ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 that employs 7,000 people. The company specializes in automation and tooling systems.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. The company operates in the medical device and healthcare sectors.

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates across imaging, medical, and industrial technology sectors.

    M.I. TECH

    M.I. Tech is a Malaysian public company founded in 2007 with 594 employees. The company operates in the technology sector.

    MICRO-TECH (NANJING) CO., LTD.

    Micro-Tech (Nanjing) Co., Ltd. is a Chinese public company founded in 2000 with 2,433 employees. The company operates in the medical device industry.

    MERIT MEDICAL SYSTEMS

    Merit Medical Systems is a United States-based public company founded in 1987 with 7,500 employees. The company manufactures and distributes medical devices and supplies.

    MEDTRONIC

    Medtronic is an Ireland-based public company founded in 1949 with 95,000 employees. The company is a global leader in medical technology, services, and solutions.

    STERIS

    STERIS is an Ireland-based public company founded in 1985. The company provides sterilization and contamination control solutions for healthcare and industrial markets.

    BD

    BD is a United States-based public company founded in 1897 with 72,000 employees. The company is a global medical technology company specializing in medical devices, diagnostics, and biosciences.

    Q3 MEDICAL GROUP

    Q3 Medical Group is an Ireland-based private company founded in 2013. The company operates in the medical device or healthcare sector.

    BVM

    BVM is a Tunisia-based public company founded in 1981 with 99 employees. The company operates in the medical or industrial sector.

    North America vs. other regions

    HowNorth America compares to the other 3 regional blocs covered in this market.

    Europe
    ~USD 218.3 Million · 5.2% wtd CAGR ·
    Asia Pacific
    ~USD 207.9 Million · 7.1% wtd CAGR ·
    Latin America
    ~USD 49.9 Million · 4.6% wtd CAGR ·
    Middle East & Africa
    ~USD 21.9 Million · 3.1% wtd CAGR ·

    Countries within North America - compare and drill down

    Country2025 size (native)
    USUSD 281.55 Million
    CanadaUSD 37.05 Million

    Country market size visualization

    US
    USD 281.55 Million
    Canada
    USD 37.05 Million

    Reasons to Buy this Report

    • Regional Market Sizing & Forecasts : Obtain precise market valuations for North America ($243.8M in 2026) with detailed 5-year forecasts to 2031, enabling accurate business planning and investment decisions specific to this high-value region.
    • Country-Level Breakdown : Access granular market data for the US and Canada separately, allowing stakeholders to identify growth opportunities and tailor strategies for each country's unique healthcare landscape and regulatory environment.
    • Competitive Intelligence : Understand North America's market dynamics, including adoption rates of minimally invasive technologies and procedural volumes, to benchmark performance and identify competitive advantages in this mature market.
    • Strategic Investment Guidance : Leverage comprehensive North America-specific insights to guide product development, market entry strategies, and partnership decisions in the world's largest gastrointestinal stent market by value.
    • Reimbursement & Regulatory Insights : Gain understanding of North America's robust reimbursement frameworks and healthcare infrastructure that support sustained market growth, critical for pricing strategy and market access planning.

    Frequently asked questions

    What is the current size of the gastrointestinal stent market in North America?

    North America's gastrointestinal stent market is valued at $243.8 million in 2026 and is expected to reach $318.6 million by 2031.

    What is the projected growth rate for North America's gastrointestinal stent market?

    North America's gastrointestinal stent market is projected to grow at a compound annual growth rate (CAGR) of 5.5% from 2026 to 2031.

    What factors are driving growth in North America's gastrointestinal stent market?

    North America's market growth is driven by advanced healthcare infrastructure, aging demographics, increasing gastrointestinal disorder prevalence, and adoption of minimally invasive stent technologies.

    Which stent types are most popular in North America?

    North America shows strong demand for self-expanding metal stents (SEMS) and fully covered stents due to improved clinical outcomes and reduced complication rates.

    How does North America's market compare to the global gastrointestinal stent market?

    North America represents a significant portion of the global market, with a 5.5% regional CAGR compared to the global 5.7% CAGR, reflecting mature market dynamics and established healthcare infrastructure.

    RESEARCH METHODOLOGY

    This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

    Secondary Research

    This research study utilized a variety of comprehensive secondary sources, including directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the gastrointestinal stent market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

    Primary Research

    In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the gastrointestinal stent market. Primary sources from the demand side include gastroenterologists, interventional endoscopists, and surgeons from hospitals and ambulatory surgical centers, as well as directors of endoscopy units and gastrointestinal clinics.

    A breakdown of the primary respondents is provided below:

    Gastrointestinal Stent Market Size, and Share

    Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

    Note 2: Other designations include sales, marketing, and product managers.

    Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the gastrointestinal stent market was determined through data triangulation using three approaches, as outlined below. After each approach, the weighted average of the three approaches was calculated based on the level of assumptions used in each.

    Gastrointestinal Stent Market : Top-Down and Bottom-Up Approach

    Gastrointestinal Stent Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed where applicable to complete the overall market engineering process and derive the exact statistics for all segments and subsegments.

    Market Definition

    The gastrointestinal stent market comprises medical devices designed for the minimally invasive management of obstructions, strictures, leaks, and fistulas within the gastrointestinal tract, including the esophagus, stomach, intestines, and biliary system. These stents, primarily self-expanding metal, plastic, and biodegradable variants, are deployed endoscopically or fluoroscopically to restore luminal patency, enable fluid drainage, and support tissue healing in both malignant and benign conditions. The market includes products, delivery systems, and associated technologies used across hospitals, ambulatory surgical centers, and specialty clinics, with applications spanning oncology, post-surgical complications, and chronic gastrointestinal disorders, driven by the growing preference for minimally invasive treatment approaches and improved patient outcomes.

    Key Stakeholders

    • GI stent manufacturers (metal, plastic, biodegradable stents)
    • Endoscopy device & delivery system manufacturers
    • Raw material & component suppliers (metals, polymers, coatings)
    • Hospitals & ambulatory surgical centers (public & private)
    • Gastroenterology clinics & endoscopy centers
    • Gastroenterologists, interventional endoscopists & GI surgeons
    • Contract manufacturers & OEM partners
    • Distributors & regional channel partners
    • Academic & clinical research institutions
    • Regulatory authorities & healthcare agencies
    • Market research & consulting firms
    • Investors & private equity firms

    Report Objectives

    • To define, describe, segment, and forecast the gastrointestinal stent market by product, type, application, end user, and region
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall gastrointestinal stent market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the gastrointestinal stent market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players in the gastrointestinal stent market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

    Customization Options:

    With the market data provided, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

    Company Information

    • Detailed analysis and profiling of additional market players (up to 5)

    Geographic Analysis

    • Further breakdown of the Rest of Europe gastrointestinal stent market into Austria, Finland, Switzerland, and other countries
    • Further breakdown of the Rest of Latin America gastrointestinal stent market into Colombia, Chile, and other countries

    Competitive Landscape Assessment

    • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the gastrointestinal stent market
    • Competitive leadership mapping for established players in the US

    Get the Full Gastrointestinal Stent Market Report

    Full forecast, segment splits, and company analysis for all Gastrointestinal Stent Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status